FACTS ABOUT MUSK TWITTER BLOCK REVEALED

Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs aimed toward growing the horizons of cytokine-based immunotherapy, specifically for cancers where therapy selections remain limited. Use the links below to learn additional about our portfolio of cytokine-based immunotherapy